Apr 1, 2025 · Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction. Ozempic …

This review will give an overview of current findings and discuss the possible mechanisms of action. We suggest that effects of GLP‐1 in alcohol and substance use disorders is mediated …

Oct 9, 2025 · Additional studies will help unveil the mechanisms underlying GLP-1 therapies in relation to addictive behaviors and substance use. But that hasn’t dampened the optimism for …

Activation of stress systems contributes to the addictive effects of various drugs of abuse, in the withdrawal and ‘negative affect’ stages of addiction (Koob, 2008; Koob & Volkow, 2016)

Nutritional status and medication side effects would require further examination and management in any potential substance use application. There’s no “quick fix” for addiction, so GLP-1 …

Apr 1, 2025 · GLP-1 receptor agonists, like semaglutide (Ozempic, Wegovy), exenatide (Bydureon), and liraglutide (Victoza), are already established treatments for diabetes and …

Nov 12, 2024 · Our organization, CASPR, is devoted to advancing novel treatments that can solve addiction at a population scale. We believe GLP-1s are the biggest breakthrough in …

Mar 31, 2025 · GLP-1 agonists have already transformed the treatment landscape for diabetes and obesity, and their potential role in addiction medicine represents an exciting new frontier.

Sep 17, 2024 · Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs typically used for weight loss and diabetes. However, early research suggests they could potentially be …

Nov 1, 2024 · Increasing evidence suggests that GLP-1 receptor agonists (GLP-1RA) have a potential use in addiction treatment. Few studies have assessed the impact of GLP-1RA on …